[Biological agents intentionally used in Poland based on data from the National Register Of Biological Agents].
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AffiliationNofer Institute of Occupational Medicine
MetadataShow full item record
Other TitlesCelowe użycie czynników biologicznych w Polsce na podstawie danych z Krajowego Rejestru Czynników Biologicznych
AbstractPaper presents the intentional use of biological agents for industrial, diagnostic and research purposes in enterprises in Poland.
The source of data is the National Register of Biological (in Polish KRCB) - the type of the database that gathers data about the intentional use of biological agents at work in Poland. The analysis includes tabular summaries of the data as of December 2017.
Notifications were sent by 598 enterprises for: diagnostic - 67.5%, research - 25% and industrial purposes - 75%. Those mostly were hospital diagnostic laboratories - 36%, entities other than hospitals - 32% and higher education and research units - 13%. In total, 4477 workers (91.3% women, 8.7% men) were exposed to biological agents. Agents from 2nd and 3rd group of risk were used in 581 and 106 enterprises, respectively. Escherichia coli bacteria was most frequently used (with the exception of non-pathogenic strains) in 504 enterprises (3529 exposed workers), Staphylococcus aureus - 495 enterprises (3464 workers) and Pseudomonas aeruginosa - 459 enterprises (3157 workers). In 58 enterprises, biological agents recognized by the International Agency for Research on Cancer as carcinogenic were used (viruses: hepatitis B virus (HBV) - 10 enterprises and 257 workers, hepatitis C virus (HCV) - 10 enterprises and 232 workers, Epstein-Barr virus (EBV) - 9 enterprises and 227 workers, human immunodeficiency virus type 1 (HIV-1) - 8 enterprises and 186 workers, human papilloma virus (HPV) - 3 enterprises and 94 workers, human herpes virus type 8 (HHV-8) - 3 enterprises and 22 workers, human T-lymphotropic virus type 1 (HTLV-1) - 1 enterprise and 17 workers; parasites: Schistosoma haematobium - 2 enterprises and 4 workers, Clonorchis viverrini - 1 enterprises and 2 workers, Clonorchis sinensis - 1 enterprises and 2 workers; bacteria: Helicobacter pylori - 10 enterprises and 137 workers).
The network organization, legal base and central nature cause that the KRCB is a unique database that allows for diagnosis of the situation and tracking of dynamics in the context of occupational exposure to biological agents used intentionally in enterprises in Poland. Med Pr 2018;69(4):413-424.
CitationMed Pr 2018, 69 (4):413-424
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Archived with thanks to Medycyna pracy
- [Harmful biological agents intentionally used in enterprises in Poland based on the National Register of Biological Agents].
- Authors: Kozajda A, Jeżak K
- Issue date: 2021 Apr 2
- [Occupational exposure to biological agents intentionally used in Polish enterprises].
- Authors: Kozajda A, Szadkowska-Stańczyk I
- Issue date: 2015
- [Carcinogenic or mutagenic chemical substances and technological processes in the workplace in Poland in 2013-2017].
- Authors: Niepsuj A, Czerczak S, Konieczko K
- Issue date: 2020 Mar 30
- [Occupational exposure to chemical carcinogens in Poland, 2001].
- Authors: Konieczko K, Czerczak S, Kluszczyński D
- Issue date: 2004
- [Activities of the National Information Center for Biological Agents present at workplace and preliminary analysis of data collected by the National Register of Biological Agents].
- Authors: Kozajda A, Szadkowska-Stańczyk I
- Issue date: 2009
Showing items related by title, author, creator and subject.
[Occupational exposure to biological agents intentionally used in Polish enterprises].Kozajda, Anna; Szadkowska-Stanczyk, Irena; Nofer Institute of Occupational Medicine, Lodz, Poland (2015)The paper presents the intentional use of biological agents for industrial, diagnostic and research purposes in Polish enterprises.
Effects of soybean glyceollins and estradiol in postmenopausal female monkeys.Wood, Charles E.; Clarkson, Thomas B.; Appt, Susan E.; Franke, Adrian A.; Boue, Stephen M.; Burow, Matthew E.; McCoy, Thomas; Cline, J. Mark (2006)Glyceollins are a novel class of soybean phytoalexins with potential cancer-protective antiestrogenic effects. The purpose of this study was to evaluate the estrogen-antagonist effects of glyceollin-enriched soy protein on biomarkers for breast cancer risk. Thirty female postmenopausal cynomolgus macaques were randomized to one of three dietary treatments for 3 wk: 1) estradiol (E2, 1 mg/day) + casein/lactalbumin (control); 2) E2 + soy protein isolate (SPI) containing 194 mg/day isoflavonoids; and 3) E2 + glyceollin-enriched soy protein (GLY) containing 189 mg/day isoflavonoids + 134 mg/day glyceollins. Doses are expressed in calorically scaled human equivalents. Mean serum glyceollin concentrations at 4 h postfeeding were 134.2 +/- 34.6 nmol/L in the GLY group and negligible in the SPI group (P = 0.0007). Breast proliferation was significantly increased in the control group (+237%, P = 0.01) but not in the SPI group (+198%, P = 0.08) or GLY group (+36%, P = 0.18). Gene expression of trefoil factor 1 and progesterone receptor, two markers of estrogen receptor activity in breast epithelium, were also significantly higher in the control (P < 0.05 for both) but not in the GLY group. These preliminary findings suggest that soybean glyceollins are natural compounds with potential estrogen-modulating properties in the breast.
Vegetable-derived isothiocyanates: anti-proliferative activity and mechanism of action.Zhang, Yuesheng; Yao, Song; Li, Jun (2006-02)Many isothiocyanates (ITC), which are available to human subjects mainly through consumption of cruciferous vegetables, demonstrate strong cancer-preventive activity in animal models. Human studies also show an inverse association between consumption of ITC and risk of cancer in several organs. Whereas earlier studies primarily focused on the ability of ITC to inhibit carcinogen-activating enzymes and induce carcinogen-detoxifying enzymes, more recent investigations have shown that ITC inhibit the proliferation of tumour cells both in vitro and in vivo by inducing apoptosis and arresting cell cycle progression. ITC cause acute cellular stress, which may be the initiating event for these effects. These findings shed new light on the mechanism of action of ITC and indicate that ITC may be useful both as cancer-preventive and therapeutic agents. ITC activate caspase 9-mediated apoptosis, apparently resulting from mitochondrial damage, and also activate caspase 8, but the mechanism remains to be defined. Cell cycle arrest caused by ITC occurs mainly in the G2/M phase, and both the G2 and M phases are targetted; critical G2-phase regulators, including cyclin B1, cell division cycle (Cdc) 2 and Cdc25C, are down regulated or inhibited, and tubulin polymerization and spindle assembly are disrupted. Moreover, ITC are metabolized in vivo through the mercapturic acid pathway, giving rise to thiol conjugates (dithiocarbamates). Studies show that these dithiocarbamates are similar to their parent ITC in exerting anti-proliferative activity. Taken together, dietary ITC are highly-promising anti-cancer agents, capable of targetting multiple cellular components that are important for tumour cell survival and proliferation.